AI assistant
Roivant Sciences Ltd. — Director's Dealing 2025
Oct 9, 2025
30587_dirs_2025-10-08_44e94654-f0ce-45e6-8c98-03efc09858cf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2025-10-06
Reporting Person: Venker Eric (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-10-06 | Common Shares | M | 127355 | $15.85 | Acquired | 1632314 | Direct |
| 2025-10-06 | Common Shares | M | 24900 | $7.45 | Acquired | 1657214 | Direct |
| 2025-10-06 | Common Shares | M | 19141 | $3.85 | Acquired | 1676355 | Direct |
| 2025-10-06 | Common Shares | S | 171396 | $16.34 | Disposed | 1504959 | Direct |
| 2025-10-07 | Common Shares | M | 67171 | $15.85 | Acquired | 1572130 | Direct |
| 2025-10-07 | Common Shares | M | 107131 | $7.45 | Acquired | 1679261 | Direct |
| 2025-10-07 | Common Shares | M | 180859 | $3.85 | Acquired | 1860120 | Direct |
| 2025-10-07 | Common Shares | S | 355161 | $16.15 | Disposed | 1504959 | Direct |
| 2025-10-08 | Common Shares | M | 10307 | $15.85 | Acquired | 1515266 | Direct |
| 2025-10-08 | Common Shares | M | 128295 | $7.45 | Acquired | 1643561 | Direct |
| 2025-10-08 | Common Shares | S | 138602 | $16.2 | Disposed | 1504959 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-10-06 | Stock Option (Right to Buy) | $15.85 | M | 127355 | Disposed | 2026-03-31 | Common Stock (127355) | Direct |
| 2025-10-06 | Stock Option (Right to Buy) | $7.45 | M | 24900 | Disposed | 2027-11-20 | Common Stock (24900) | Direct |
| 2025-10-06 | Stock Option (Right to Buy) | $3.85 | M | 19141 | Disposed | 2032-04-19 | Common Stock (19141) | Direct |
| 2025-10-07 | Stock Option (Right to Buy) | $15.85 | M | 67171 | Disposed | 2026-03-31 | Common Stock (67171) | Direct |
| 2025-10-07 | Stock Option (Right to Buy) | $7.45 | M | 107131 | Disposed | 2027-11-20 | Common Stock (107131) | Direct |
| 2025-10-07 | Stock Option (Right to Buy) | $3.85 | M | 180859 | Disposed | 2032-04-19 | Common Stock (180859) | Direct |
| 2025-10-08 | Stock Option (Right to Buy) | $15.85 | M | 10307 | Disposed | 2026-03-31 | Common Stock (10307) | Direct |
| 2025-10-08 | Stock Option (Right to Buy) | $7.45 | M | 128295 | Disposed | 2027-11-20 | Common Stock (128295) | Direct |
Footnotes
F1: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on March 28, 2025.
F2: Award of stock options to purchase Common Shares with a vesting commencement date of December 27, 2019. These options are fully vested.
F3: Award of stock options to purchase Common Shares with a vesting commencement date of October 16, 2017. These options are fully vested.
F4: Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation).